about
Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.Recent advances in oncolytic adenovirus therapies for cancer.Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells.Cowpox Virus: A New and Armed Oncolytic Poxvirus.CARs on a highway with roadblocks.Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.Trial watch: Immune checkpoint blockers for cancer therapy.Designing and building oncolytic viruses.Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro.The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.Updates on immunotherapy for colorectal cancer.Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites.Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapiesTrial watch: DNA-based vaccines for oncological indicationsWhite paper on microbial anti-cancer therapy and preventionAPOBEC3 Mediates Resistance to Oncolytic Viral TherapyTherapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
P2860
Q33914097-1850D304-8779-4F79-90D8-105118C8ED8EQ36380295-83A097FF-EAC0-490A-8938-F102F4265F3CQ38886593-B8794500-DD54-4A8D-A809-BDCFDBFE94EBQ39387174-FC0102F9-F3B8-42AA-BC70-9DD4DDEA8469Q40064004-2E50898C-66CD-4096-9B4A-37840E85C456Q40200208-A6172450-5343-4E35-BB02-2058202C30CBQ41688010-6CED739D-326D-4CC0-A0E6-E2E95383C6C3Q41689720-43EA527B-1F99-404B-B12B-2894ADA4480CQ45875485-5B847E9B-720E-4E93-A934-2E3AED77F5DEQ46210737-FDE2ECA7-CC42-4DB6-ABEC-8B9BE3322980Q47325431-5DAE8AD9-61EB-4C07-A25A-7BB630546F69Q47326177-2660E964-30E9-4454-BF65-CB9CCE03E3A3Q47393365-356C522C-FC9D-46F5-ABEF-965B62312E16Q47547386-55F51A69-EE44-4F7B-A9FF-854264A665F1Q47562626-153ABD09-E92E-4A62-8A26-7FF144F84F3BQ51734249-200D0BD3-6FDB-4FCA-ADF1-632CE2A33BB5Q52594999-9D08B95F-0454-4C76-BB53-C0B957E2ED71Q52643529-9641B34B-175D-4C9F-BEE2-C71F07887F75Q55516215-5A81E5D0-B60C-43DD-9540-E8F2E9D900E8Q56892795-A470B3CA-DD17-4601-9A54-16CBFBF010B2Q56893452-BBEFEF50-C7D2-49BB-BA77-B92101683FA2Q56898750-9773ADF1-9783-4EEC-A6EE-5D90408DD4DDQ57192791-272720F4-2CF7-4C7F-B6E1-821D0BCA7B2FQ57462243-C73EDC75-13EB-4746-BF2A-63C9D161D2E0
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Trial Watch-Oncolytic viruses and cancer therapy
@ast
Trial Watch-Oncolytic viruses and cancer therapy
@en
Trial Watch-Oncolytic viruses and cancer therapy
@nl
type
label
Trial Watch-Oncolytic viruses and cancer therapy
@ast
Trial Watch-Oncolytic viruses and cancer therapy
@en
Trial Watch-Oncolytic viruses and cancer therapy
@nl
prefLabel
Trial Watch-Oncolytic viruses and cancer therapy
@ast
Trial Watch-Oncolytic viruses and cancer therapy
@en
Trial Watch-Oncolytic viruses and cancer therapy
@nl
P2093
P2860
P50
P1433
P1476
Trial Watch-Oncolytic viruses and cancer therapy
@en
P2093
Jean-Marc Limacher
Jitka Fucikova
Norma Bloy
Philippe Erbs
Radek Spisek
Xavier Preville
P2860
P304
P356
10.1080/2162402X.2015.1117740
P407
P50
P577
2015-12-08T00:00:00Z